Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 286 AL 300

Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial

Vossel K, Ranasinghe KG, Beagle AJ, La A, Ah Pook K, Castro M, Mizuiri D, Honma SM, Venkateswaran N, Koestler M, Zhang W, Mucke L, Howell MJ, Possin KL, Kramer JH, Boxer AL, Miller BL, Nagarajan SS, Kirsch HE.

JAMA Neurol. 2021 Nov 1;78(11):1345-1354. doi: 10.1001/jamaneurol.2021.3310.

Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial

Mintzer J, Lanctôt KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D; ADMET 2 Research Group.

JAMA Neurol. 2021 Nov 1;78(11):1324-1332. doi: 10.1001/jamaneurol.2021.3356.

Brain Renin-Angiotensin System as Novel and Potential Therapeutic Target for Alzheimer's Disease

Loera-Valencia R, Eroli F, Garcia-Ptacek S, Maioli S.

Int J Mol Sci. 2021 Sep 20;22(18):10139. doi: 10.3390/ijms221810139.

Cashew Nut Shell Liquid (CNSL) as a Source of Drugs for Alzheimer's Disease

Uliassi E, de Oliveira AS, de Camargo Nascente L, Romeiro LAS, Bolognesi ML.

Molecules. 2021 Sep 7;26(18):5441. doi: 10.3390/molecules26185441.

Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources

Tamfu AN, Kucukaydin S, Yeskaliyeva B, Ozturk M, Dinica RM.

Molecules. 2021 Sep 14;26(18):5582. doi: 10.3390/molecules26185582.

Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease

Jain D, Rashid MA, Ahmad FJ.

Curr Pharm Des. 2021;27(43):4388-4403. doi: 10.2174/1381612827666210927163258.

The Cost-Effectiveness of Three Prevention Strategies in Alzheimer's Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT)

Costa N, Mounié M, Pagès A, Derumeaux H, Rapp T, Guyonnet S, Coley N, Cantet C, Carrié I, Andrieu S, Molinier L.

J Prev Alzheimers Dis. 2021;8(4):425-435. doi: 10.14283/jpad.2021.47.

Nano-lipidic formulation and therapeutic strategies for Alzheimer's disease via intranasal route

Tripathi S, Gupta U, Ujjwal RR, Yadav AK.

J Microencapsul. 2021 Nov-Dec;38(7-8):572-593. doi: 10.1080/02652048.2021.1986585. Epub 2021 Nov 9.

Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations

Mani S, Swargiary G, Singh M, Agarwal S, Dey A, Ojha S, Jha NK.

Life Sci. 2021 Nov 15;285:119985. doi: 10.1016/j.lfs.2021.119985. Epub 2021 Sep 27.

Probiotics as potential therapeutic options for Alzheimer's disease

Ji HF, Shen L.

Appl Microbiol Biotechnol. 2021 Oct;105(20):7721-7730. doi: 10.1007/s00253-021-11607-1. Epub 2021 Oct 1.

Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease

Han J, Du Z, Lim MH.

Acc Chem Res. 2021 Oct 19;54(20):3930-3940. doi: 10.1021/acs.accounts.1c00457. Epub 2021 Oct 4.

Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties

Siddiqui A, Shah Z, Jahan RN, Othman I, Kumari Y.

Biomed Pharmacother. 2021 Dec;144:112250. doi: 10.1016/j.biopha.2021.112250. Epub 2021 Oct 1.

Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010-2020)

Li Y, Sang S, Ren W, Pei Y, Bian Y, Chen Y, Sun H.

Eur J Med Chem. 2021 Dec 15;226:113874. doi: 10.1016/j.ejmech.2021.113874. Epub 2021 Sep 27.

New trends in pharmacological control of neuropsychiatric symptoms of dementia

Scuteri D, Corasaniti MT, Tonin P, Nicotera P, Bagetta G.

Curr Opin Pharmacol. 2021 Dec;61:69-76. doi: 10.1016/j.coph.2021.09.002. Epub 2021 Oct 9.

Exploring Aβ Proteotoxicity and Therapeutic Candidates Using Drosophila melanogaster

Elovsson G, Bergkvist L, Brorsson AC.

Int J Mol Sci. 2021 Sep 28;22(19):10448. doi: 10.3390/ijms221910448.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias